BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Krystal Biotech Announces First Quarter 2023 Financial Results and Operational Highlights

  Krystal Biotech, Inc. today reported financial results and key operational progress updates for the first quarter ended March 31, 2023.

  May 8, 2023

   · 

  9 min read
• Genetown

  Cerevance to Present at the 2023 RBC Capital Markets Global Healthcare Conference

  Cerevance today announced that Craig Thompson, chief executive officer of Cerevance, will present at the upcoming 2023 RBC Capital Markets Global Healthcare Conference being held May 16-17, 2023.

  May 8, 2023

   · 

  1 min read
• Business

  Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023Management to Host Conference Call

  Minerva Neurosciences, Inc. today announced that it will release first quarter 2023 financial results and business updates on Monday, May 15, 2023.

  May 8, 2023

   · 

  1 min read
• Business

  Longeveron to Announce First Quarter 2023 Financial Results on May 12, 2023Live conference call on Friday, May 12 at 8:30 a.m. ET

  Longeveron Inc. today announced that the Company will release its first quarter 2023 financial results on Friday, May 12, 2023 before the open of the U.S. financial markets.

  May 8, 2023

   · 

  1 min read
• Biotech Beach

  Tarsus Launches “Don’t Freak Out. Get Checked Out.” Campaign During Healthy Vision Month to Encourage Patients with Demodex Blepharitis to Visit Eye Care Providers

  Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced the launch of “Don’t Freak Out.

  May 8, 2023

   · 

  7 min read
• Business

  Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update

  Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported financial results for the first quarter ended March 31, 2023, and provided an update on recent clinical and development pipeline progress.

  May 8, 2023

   · 

  9 min read
• Business

  Dyadic Announces Collaboration to Commercialize Animal-Free Alternative Proteins Using Dapibus™

  Dyadic International, Inc. announced that it entered into a co-development and marketing agreement with Fermbox Bio Inc.

  May 8, 2023

   · 

  5 min read
• Business

  CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023

  CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2023, after market close on Monday, May 15, 2023, and will host a corporate update conference call at 4:30pm Eastern Time.

  May 8, 2023

   · 

  2 min read
• Bio NC

  Dentsply Sirona to Participate in Upcoming Investor Conferences

  DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced its participation at upcoming conferences.

  May 8, 2023

   · 

  1 min read
• BioMidwest

  Mirati Therapeutics and Sarah Cannon Research Institute Announce Strategic, Community Site Focused Partnership to Increase Diversity in Oncology Clinical Studies

  Mirati Therapeutics, Inc.® and Sarah Cannon Research Institute announced a strategic partnership aimed at increasing diversity in clinical study recruitment practices.

  May 8, 2023

   · 

  5 min read